Literature DB >> 11565135

Natural history of portal hypertension in patients with cirrhosis.

R de Franchis1, M Primignani.   

Abstract

All patients with cirrhosis will eventually develop portal hypertension and esophagogastric varices. Bleeding from ruptured esophagogastric varices is the most severe complication of cirrhosis and is the cause of death in about one third of patients. The rate of development and growth of esophageal varices is poorly defined but in general seem to be related to the degree of liver dysfunction. Once varices have formed, they tend to increase in size and eventually to bleed. In unselected patients, the incidence of variceal bleeding is about 20% to 30% at 2 years. Variceal size is the single most important predictor of a first variceal bleeding episode. Several prognostic indexes based on endoscopic and clinical parameters have been developed to predict the risk of bleeding; however, their degree of accuracy is unsatisfactory. Death caused by uncontrolled bleeding occurs in about 6% to 8% of patients; the 6-week mortality rate after a variceal hemorrhage is 25% to 30%. There are no good prognostic indicators of death caused by uncontrolled bleeding or death within 6 weeks. Untreated patients surviving a variceal hemorrhage have a 1- to 2-year risk of rebleeding of about 60% and a risk of death of about 40% to 50%. The risk of bleeding is greatest in the first days after a bleeding episode and slowly declines thereafter. All patients surviving a variceal hemorrhage must be treated to prevent rebleeding. Varices can also be found in the stomach of cirrhotic patients, alone or in association with esophageal varices. Gastric varices bleed less frequently but more severely than esophageal varices. Portal hypertensive gastropathy is a common feature of cirrhosis, and its prevalence parallels the severity of portal hypertension and liver dysfunction. Portal hypertensive gastropathy can progress from mild to severe and vice-versa or even disappear completely. Acute bleeding from portal hypertensive gastropathy seems to be relatively uncommon, and less severe than bleeding from varices.

Entities:  

Mesh:

Year:  2001        PMID: 11565135     DOI: 10.1016/s1089-3261(05)70186-0

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  88 in total

1.  Post-gastrectomy spleen enlargement and esophageal varices: distal vs total gastrectomy.

Authors:  Takatsugu Oida; Kenji Mimatsu; Hisao Kano; Atsushi Kawasaki; Youichi Kuboi; Nobutada Fukino; Sadao Amano
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

Review 2.  Trends on gastrointestinal bleeding and mortality: where are we standing?

Authors:  Ahmed Mahmoud El-Tawil
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

3.  Percutaneous transhepatic embolization of gastroesophageal varices combined with partial splenic embolization for the treatment of variceal bleeding and hypersplenism.

Authors:  Wei-Dong Gong; Ke Xue; Yuan-Kui Chu; Qing Wang; Wei Yang; Hui Quan; Peng Yang; Zhi-Min Wang; Zhi-Qun Wu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  A case of spontaneous splenorenal shunt associated with splenic artery aneurysm.

Authors:  Shogo Hayashi; Shuang-Qin Yi; Munekazu Naito; Hayato Terayama; Sichen Buhe; Yoichi Nakamura; Takayoshi Miyaki; Masahiro Itoh
Journal:  Surg Radiol Anat       Date:  2006-04-27       Impact factor: 1.246

Review 5.  Current management of the complications of portal hypertension: variceal bleeding and ascites.

Authors:  Nina Dib; Frédéric Oberti; Paul Calès
Journal:  CMAJ       Date:  2006-05-09       Impact factor: 8.262

6.  Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage.

Authors:  Shou-Wu Lee; Teng-Yu Lee; Chi-Sen Chang
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

7.  Haematemesis and melaena [corrected] as the first presentation of duodenal varices.

Authors:  L Ryan; R Bethune; K Habeeb
Journal:  J R Soc Med       Date:  2010-03       Impact factor: 5.344

8.  Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.

Authors:  Paolo Fonio; Andrea Discalzi; Marco Calandri; Andrea Doriguzzi Breatta; Laura Bergamasco; Silvia Martini; Antonio Ottobrelli; Dorico Righi; Giovanni Gandini
Journal:  Radiol Med       Date:  2017-05-16       Impact factor: 3.469

Review 9.  Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

Authors:  Sith Siramolpiwat
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis.

Authors:  E Giannini; F Botta; P Borro; D Risso; P Romagnoli; A Fasoli; M R Mele; E Testa; C Mansi; V Savarino; R Testa
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.